Facile one-pot strategy for brain imaging using radiolabeled [99mTc]-tricarbonyl histamine complex in Mice.

Document Type : Original Article

Authors

1 Labeled Compound Department, Hot Laboratory Centre, Egyptian Atomic Energy Authority, P.O. Box 13755, Cairo, Egypt

2 Radiation Chemistry Department, National Centre for Radiation Research and Technology, Egyptian Atomic Energy, Authority, P.O. Box 11787, Cairo, Egypt.

3 Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, 12578 Egypt.

4 Drug Radiation Research Department, National Centre for Radiation Research and Technology, Egyptian Atomic Energy, Authority, P.O. Box 11787, Cairo, Egypt.

5 Radiation Biology Department, National Centre for Radiation Research and Technology, Egyptian Atomic Energy Authority, P.O. Box 11787, Cairo, Egypt.

Abstract

This investigation aims to label the histamine ligand, 2-(1H-imidazol-4-yl) ethanamine, using a [99mTc]-tricarbonyl core method for brain imaging. The optimization of all variables and factors influencing the radiochemical reaction is carried out to produce the labeled compound with a high radiochemical yield of 98.5%. The radiolabeled compound was stable for up to 6 hours, with a logarithm of the partition coefficient value at 1.49 ± 0.04. This value suggests the lipophilic characteristics of the [99mTc]-tricarbonyl histamine compound, indicating its potential to cross the blood-brain barrier effectively. The bioevaluation of the radiotracer [99mTc]-tricarbonyl-histamine complex exhibited a notable brain uptake of 8.5% ID/organ at 5 minutes post-injection and, eliminated through the urinary system within 2 hours post-injection. This study explores the promising developments in brain imaging facilitated by the [99mTc]-tricarbonyl histamine complex.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 21 July 2024
  • Receive Date: 17 April 2024
  • Revise Date: 12 July 2024
  • Accept Date: 21 July 2024